首页> 外文期刊>Diabetes >Association of Genetic Loci With Glucose Levels in Childhood and Adolescence A Meta-Analysis of Over 6,000 Children
【24h】

Association of Genetic Loci With Glucose Levels in Childhood and Adolescence A Meta-Analysis of Over 6,000 Children

机译:遗传位点与儿童和青春期葡萄糖水平的关联对6,000多名儿童的荟萃分析

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE—To investigate whether associations of common genetic variants recently identified for fasting glucose or insulin levels in nondiabetic adults are detectable in healthy children and adolescents. RESEARCH DESIGN AND METHODS—A total of 16 single nucleotide polymorphisms (SNPs) associated with fasting glucose were genotyped in six studies of children and adolescents of European origin, including over 6,000 boys and girls aged 9-16 years. We performed meta-analyses to test associations of individual SNPs and a weighted risk score of the 16 loci with fasting glucose. RESULTS—Nine loci were associated with glucose levels in healthy children and adolescents, with four of these associations reported in previous studies and five reported here for the first time (GLIS3, PROX1, SLC2A2, ADCY5, and CRYZ). Effect sizes were similar to those in adults, suggesting age-independent effects of these fasting glucose loci. Children and adolescents carrying glucose-raising alleles of G6PC2, MTNR1B, GCK, and GLIS3 also showed reduced p-cell function, as indicated by ho-meostasis model assessment of p-cell function. Analysis using a weighted risk score showed an increase [β (95% CI)] in fasting glucose level of 0.026 mmol/L (0.021-0.031) for each unit increase in the score. CONCLUSIONS—Novel fasting glucose loci identified in genome-wide association studies of adults are associated with altered fasting glucose levels in healthy children and adolescents with effect sizes comparable to adults. In nondiabetic adults, fasting glucose changes little over time, and our results suggest that age-independent effects of fasting glucose loci contribute to long-term interindividual differences in glucose levels from childhood onwards. Diabetes 60:1805-1812, 2011
机译:目的—研究在健康的儿童和青少年中是否可以检测到最近发现的非糖尿病成年人空腹血糖或胰岛素水平常见遗传变异的关联。研究设计与方法—在六项来自欧洲的儿童和青少年的研究中,共进行了16种与空腹血糖相关的单核苷酸多态性(SNP)的基因分型,其中包括6,000多名9-16岁的男孩和女孩。我们进行了荟萃分析,以测试单个SNP的关联以及空腹血糖对16个基因座的加权风险评分。结果—在健康儿童和青少年中,有9个基因座与血糖水平相关,在先前的研究中报道了其中4个关联,在这里首次报道了5个关联(GLIS3,PROX1,SLC2A2,ADCY5和CRYZ)。影响大小与成人相似,表明这些空腹葡萄糖基因座的年龄独立影响。携带G6PC2,MTNR1B,GCK和GLIS3的葡萄糖升高等位基因的儿童和青少年也显示p细胞功能降低,这是通过对p细胞功能的稳态模型评估得出的。使用加权风险评分进行的分析表明,每增加一个评分,空腹血糖水平就会增加[β(95%CI)] 0.026 mmol / L(0.021-0.031)。结论—在成年人的全基因组关联研究中确定的新的空腹血糖基因位点与健康儿童和青少年的空腹血糖水平改变有关,其影响大小可与成人相媲美。在非糖尿病成年人中,空腹血糖随时间变化很小,我们的研究结果表明,从童年开始,空腹血糖位点的年龄独立效应会导致长期的个体血糖水平差异。糖尿病60:1805-1812,2011

著录项

  • 来源
    《Diabetes》 |2011年第6期|p.1805-1812|共8页
  • 作者单位

    Medical Research Council Epidemiology Unit, Addenbrooke's Hospital, Institute of Metabolic Science, Cambridge, U.K;

    Medical Research Council Epidemiology Unit, Addenbrooke's Hospital, Institute of Metabolic Science, Cambridge, U.K;

    MRC Centre forCausal Analyses in Translational Epidemiology (MRC CAiTE), University ofBristol, Bristol, U.K,School of Social and Community Medicine, University of Bristol, Bristol, U.K;

    CNRS UMR 8199, Institut Pasteur de Lille,Lille, France,Lille Nord de France University, Lille, France;

    School ofWomen's and Infants' Health, The University of Western Australia, Perth,Western Australia;

    Department of Nutrition-Dietetics, Harokopio University, Athens, Greece,Wellcome Trust Sanger Institute, Wellcome TrustGenome Campus, Hinxton, U.K.;

    School of Medicine and Pharmacology, The University of Western Australia, Perth, Western Australia;

    Medical Research Council Epidemiology Unit, Addenbrooke's Hospital, Institute of Metabolic Science, Cambridge, U.K;

    Wellcome Trust Sanger Institute, Wellcome TrustGenome Campus, Hinxton, U.K.;

    MRC Centre forCausal Analyses in Translational Epidemiology (MRC CAiTE), University ofBristol, Bristol, U.K;

    University of Southern Denmark, Odense, Denmark;

    Oxford Centre forDiabetes, Endocrinology and Metabolism, University of Oxford, Oxford,U.K;

    MRC Centre forCausal Analyses in Translational Epidemiology (MRC CAiTE), University ofBristol, Bristol, U.K,School of Social and Community Medicine, University of Bristol, Bristol, U.K;

    CNRS UMR 8199, Institut Pasteur de Lille,Lille, France,Lille Nord de France University, Lille, France;

    Medical Research Council Epidemiology Unit, Addenbrooke's Hospital, Institute of Metabolic Science, Cambridge, U.K;

    Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada;

    Oxford Centre forDiabetes, Endocrinology and Metabolism, University of Oxford, Oxford,U.K,Wellcome Trust Centre for HumanGenetics, University of Oxford, Oxford, U.K.;

    School of Medicine and Pharmacology, The University of Western Australia, Perth, Western Australia;

    Cardiovascular Genetics"Research Unit, Université Henri Poincaré, Nancy, France;

    School ofWomen's and Infants' Health, The University of Western Australia, Perth,Western Australia;

    Department of Nutrition-Dietetics, Harokopio University, Athens, Greece;

    School ofWomen's and Infants' Health, The University of Western Australia, Perth,Western Australia;

    School of Social and Community Medicine, University of Bristol, Bristol, U.K,The Avon Longitudinal Study of Parents and Children, University of Bristol, Bristol, U.K.;

    Oxford Centre forDiabetes, Endocrinology and Metabolism, University of Oxford, Oxford,U.K,Wellcome Trust Centre for HumanGenetics, University of Oxford, Oxford, U.K.;

    School of Social and Community Medicine, University of Bristol, Bristol, U.K,The Avon Longitudinal Study of Parents and Children, University of Bristol, Bristol, U.K.;

    British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, U.K.;

    Cardiovascular Genetics"Research Unit, Université Henri Poincaré, Nancy, France;

    Department of Nutrition-Dietetics, Harokopio University, Athens, Greece;

    Ontario Institute for Cancer Research,University of Toronto, Toronto, Canada;

    CNRS UMR 8199, Institut Pasteur de Lille,Lille, France,Lille Nord de France University, Lille, France,Department of Genomics ofCommon Disease, School of Public Health, Imperial College London, Hammersmith Hospital, London, U.K.;

    MRC Centre forCausal Analyses in Translational Epidemiology (MRC CAiTE), University ofBristol, Bristol, U.K,School of Social and Community Medicine, University of Bristol, Bristol, U.K;

    Medical Research Council Epidemiology Unit, Addenbrooke's Hospital, Institute of Metabolic Science, Cambridge, U.K,School of Health and MedicalSciences, Orebro University, Orebro, Sweden;

    Medical Research Council Epidemiology Unit, Addenbrooke's Hospital, Institute of Metabolic Science, Cambridge, U.K;

    Medical Research Council Epidemiology Unit, Addenbrooke's Hospital, Institute of Metabolic Science, Cambridge, U.K;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:34

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号